Takeda has a variety of resources to help people living with von Willebrand disease, including information, guidance, and resources regarding treatment. Talk to your healthcare provider about your goals for treatment.
Ask your healthcare provider if you may be eligible to receive trial doses of VONVENDI with or without FVIII. This Free trial program is for new VONVENDI patients only. Participants must receive consultation and approval from a healthcare provider to participate.*
VONVENDI on-demand and surgery treatment with or without recombinant factor VIII (rFVIII) details:
VONVENDI for prophylaxis in patients with severe Type 3 VWD receiving on-demand therapy details:
*Other restrictions may apply. See Program Terms & Eligibility in the below linkDownload the forms
If you are an adult patient new to VONVENDI you may be able to receive a Patient Starter Kit at no cost to you.
Sign up to request a starter kit and receive updates from VONVENDI.Sign up now
This brochure can help you decide if you should talk to your healthcare provider about using VONVENDI to manage your bleeding episodes. It includes information about VWD, treatment with VONVENDI, and programs from Takeda.Download the brochure
Our easy-to-use Discussion Guide, used alongside our bleed tracker, can help you speak to your healthcare provider about finding a treatment that's right for you.Download the guide
Takeda Hematology Support Center (HSC) is a dedicated team for eligible patients who have been prescribed Takeda hematology products. HSC assists patients affected by bleeding disorders in gaining access to the Takeda medication prescribed by their physician as well as providing educational resources and information on financial assistance options. Call 1-888-229-8379 Monday–Friday | 8:30AM–8:00PM ETVisit HematologySupport.com
If you have been prescribed VONVENDI, here are a few ways that the HSC can help:
Case Managers are a patient's first point of contact. They can assist with CoPay enrollment and will connect patients to other HSC team members if additional information is required.
For eligible commercially insured Takeda patients, the CoPay assistance program may cover 100% of eligible out-of-pocket expenses related to a patient’s Takeda Hematology treatment for which there is a co-pay, such as deductibles and coinsurances, up to the program maximum.†
Our Patient Access Managers are insurance experts who are trained to help address potential access challenges with Takeda prescribed treatment. PAMs can:
If your healthcare provider prescribed VONVENDI, they can sign you up for self-infusion trainings through HSC. A specially trained nurse can teach you to self-infuse at home or virtually. Talk to your healthcare provider to see if self-infusion may be right for you.
Insurance education resources are available to help patients understand insurance and the evolving healthcare landscape. Additionally, HSC connects patients and caregivers with community resources and additional tools available for those living with a bleeding disorder. Healthcare Educators are also a part of the HSC team and are fluent in both Spanish and English. They can provide one-on-one education to caregivers and patients on managing their condition.
†IMPORTANT NOTICE: Takeda's HSC Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 888-229-8379. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.
Through VWiD, adults living with VWD can attend events to hear from VONVENDI users and Takeda Senior Clinical Specialists. Contact your local National Hemophilia Foundation chapter for more information.Find your chapter
See Detailed Important Risk Information
What is VONVENDI?
VONVENDI is used in adults (age 18 years and older) diagnosed with von Willebrand disease to:
Who should not use VONVENDI?
You should not use VONVENDI if you: